Our News on Newswise

$3M Robert Wood Johnson Foundation grant to fund gun violence research

UC Davis Health received a $3 million grant to support research by the Black & Brown Collective. The group is studying gun violence that disproportionately impacts marginalized communities.
27-Mar-2024 12:05 PM EDT Add to Favorites

Human brains are getting larger. That may be good news for dementia risk

A new study published in JAMA Neurology found human brains are getting bigger. The increased size may lead to a brain reserve, potentially reducing the risk of dementia.
25-Mar-2024 4:05 PM EDT Add to Favorites

How firearms move from legal purchase to criminal use

A new study of California firearm data identifies specific risk factors associated with a legally purchased gun that is later used in a crime.
25-Mar-2024 11:05 AM EDT Add to Favorites

Experts warn climate change will fuel spread of infectious diseases

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.
20-Mar-2024 1:05 PM EDT Add to Favorites

Report finds California's mental health crisis programs need consistent funding, community engagement

UC Davis health researchers evaluated California’s mental health crisis management and prevention programs. Their report identified gaps in the system and called for more sustainable programs and community collaborations to support people with...
19-Mar-2024 12:05 PM EDT Add to Favorites

Lower grades, more absences for high schoolers who use both tobacco and cannabis

Students who use both tobacco and cannabis (marijuana) have lower grades and miss more school than students who only use one product or don’t use either. Tobacco consumption among high school students, including vaping and e-cigarettes, is a...
14-Mar-2024 4:05 PM EDT Add to Favorites

UC Davis Health team uses AI to predict risk of liver cancer

A team at UC Davis has developed a machine-learning model that can better predict which patients are at greater risk to develop hepatocellular carcinoma.
29-Feb-2024 1:05 PM EST Add to Favorites

Newswise: 65d6510481994_2023-08-21Wancancerresearch122.jpg

TB vaccine shrinks liver cancer tumors in mice

Could the TB vaccine be a new immunotherapy for liver cancer? A UC Davis Health study found that the century-old vaccine reduced tumors and extended survival for mice with liver cancer.
21-Feb-2024 2:05 PM EST Add to Favorites


See All News

Our Experts on Newswise

Florette K. Gray Hazard appointed chair of Pathology and Laboratory Medicine

Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400...
4-Mar-2024 6:05 PM EST

Are over-the-counter eye drops safe?

Dozens of eye drop recalls this year have left consumers confused about product safety. An expert explains why there have been so many recalls and how to pick safe eye drops.
19-Dec-2023 2:05 PM EST

Kids don't know they need glasses: 7 vision tips for parents

Can your child see the blackboard at school? Ophthalmologist Marcela Maria Estrada explains why kids often don’t know they have bad eyesight and gives tips for healthy vision.
18-Aug-2023 2:35 PM EDT

Anxiety disorders will affect nearly 1 in 3 adults: Here’s what you need to know

A UC Davis expert explains anxiety versus fear and how anxiety disorders can be effectively treated with therapy, medications and self-care.
10-May-2023 6:20 PM EDT

Extreme Risk Protection Orders to Prevent Mass Shootings: What Does the Research Show?

Mass shooters frequently share their plans, creating opportunities to intervene. Experts from the UC Davis Violence Prevention Research Program provide an overview of the research on mass shootings and the “red flag” laws or extreme risk...
24-Jun-2022 9:20 AM EDT

See All Experts

Our YouTube Videos

About

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists.

Experts

Contacts

Andon Carling
Web Communications

aacarling@ucdavis.edu

916-734-9430

Liam Connolly
Senior Public Information Officer

lhconnolly@ucdavis.edu

916-752-6480

Edwin Garcia
Public Information Officer

edmgarcia@ucdavis.edu

916-734-9323

Lisa Howard
Senior Public Information Officer

lehoward@ucdavis.edu

916-752-6394

Main Public-box

HS-publicaffairs@ucdavis.edu

Doreen Purvis
Administrative Assistant - Public Affairs and Marketing

dpurvis@ucdavis.edu

916-734-9450

Marianne Sharp
Senior Public Information Officer

marsharp@ucdavis.edu

916-734-9118

Tricia Tomiyoshi
Senior Public Information Officer

ttomiyoshi@ucdavis.edu

916-734-9706

Stephanie Winn
Senior PIO
Comprehensive Cancer Ctr.

stawinn@ucdavis.edu

916 501-9864

Pamela Wu
Director, Communications and Media Relations

pcwu@ucdavis.edu

916-734-9040

Nadine Yehya
Science Writer

nyehya@ucdavis.edu

Twitter

close
0.31435